According to the research report titled ‘Global Molecular Imaging Equipment Market 2022-2028’, available with MarketStudyReport, global molecular imaging equipment market is expected to reach USD 3,469 million by the year 2028, recording a 6.2% CAGR.

The surging prevalence of chronic ailments, increasing geriatric population, technological advancements, and rising disposable income are some of the prominent factors driving the expansion of global molecular imaging equipment market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042735/  

Molecular Imaging (MI) is a rapidly growing biomedical research discipline that allows for the characterization, visualization, and quantitative determination of biological processes occurring at the subcellular and cellular levels within intact living subjects, including patients, rather than traditional methods for obtaining molecular information from preserved tissue samples, such as histology.

Notably, the report offers in-depth research into the present business vertical, as well as the key trends and factors driving the overall market growth. It provides a unique perspective on market size, major trends, the competitive landscape, growth rate, and market segments. The influence of the COVID-19 crisis on global molecular imaging equipment marketplace has also been examined in this report.

This industry research report includes predictions of the various market segmentations, such as product landscape, application spectrum, end-user terrain, and regional contribution.

Based on the product landscape, the market is fragmented in terms of PET/MRI systems, PET/CT systems, SPECT systems, and SPECT/CT systems. Moving on to the application spectrum, the market is segmented into clinical applications and preclinical research.

With respect to the end-user terrain, the industry is categorized into ambulatory surgical centers (ASCs), specialty clinics, hospitals, and others.

On the basis of regional contribution, the market is divided into Asia Pacific, North America, Europe, Rest of the World.

United Imaging Healthcare Co. Ltd., Spectrum Dynamics Medical Inc., Siemens Healthineers AG, Neusoft Corporation, MiE Medical Imaging Electronics GmbH, Mediso Ltd., Koninklijke Philips N.V., GE Healthcare, Digirad Corporation, DDD-Diagnostic A/S, CMR Naviscan Corporation, and Canon Medical Systems Corporation are the leading companies defining global molecular imaging equipment industry trends.